Pee Cee Cosma

  • Market Cap: Micro Cap
  • Industry: FMCG
  • ISIN: INE417E01010
  • NSEID:
  • BSEID: 524136
INR
394.00
7.35 (1.9%)
BSENSE

Dec 05

BSE+NSE Vol: 148

  • Price Points
  • Score
  • Mojo Parameters
  • Total Return
  • News and Corporate Actions
  • Key factors
  • Shareholding
  • Financials
  • CompanyCV
stock-summaryPrice Point
High/Low

1Day

52 Week

Valuation
Technical
Day's Volume

CASH

148 (-29.46%) Volume

Shareholding (Sep 2025)

FII

0.00%

Held by 0 FIIs

DII

0.78%

Held by 0 DIIs

Promoter

72.58%

how big is Pee Cee Cosma?

06-Jun-2025

As of Jun 06, Pee Cee Cosma Sope Ltd has a market capitalization of 129.00 Cr, with recent net sales of 131.98 Cr and net profit of 8.96 Cr over the last four quarters. Shareholder's funds are valued at 40.28 Cr, and total assets amount to 47.84 Cr.

Market Cap: As of Jun 06, Pee Cee Cosma Sope Ltd has a market capitalization of 129.00 Cr, classified as a Micro Cap.<BR><BR>Recent Quarterly Performance: For the latest 4 quarters, the company reported a sum of Net Sales of 131.98 Cr and a sum of Net Profit of 8.96 Cr. This data is on a Consolidated basis.<BR><BR>Balance Sheet Snapshot: The Balance Sheet data is Standalone and pertains to the reporting period of Mar'24. Shareholder's Funds are valued at 40.28 Cr, while Total Assets amount to 47.84 Cr.

Read More

Who are in the management team of Pee Cee Cosma?

06-Jun-2025

As of March 2022, the management team of Pee Cee Cosma includes Mayank Jain (Chairman & Wholetime Director), Ankur Jain (Managing Director), and several independent directors, including Nemi Chandra Jain, Anil Gupta, Babita Agarwal, and K Agarwal, along with Nidhi Agarwal (Company Secretary) and Ankit Jain (Whole-time Director). This team oversees the company's operations and regulatory compliance.

As of March 2022, the management team of Pee Cee Cosma includes the following members:<BR><BR>1. Nemi Chandra Jain - Independent Director<BR>2. Nidhi Agarwal - Company Secretary & Compliance Officer<BR>3. Anil Gupta - Independent Director<BR>4. Babita Agarwal - Independent Director<BR>5. Mayank Jain - Chairman & Wholetime Director<BR>6. Ankur Jain - Managing Director<BR>7. Ankit Jain - Whole-time Director<BR>8. K Agarwal - Independent Director<BR><BR>This team is responsible for overseeing the company's operations and ensuring compliance with regulations.

Read More

Has Pee Cee Cosma declared dividend?

06-Jun-2025

Yes, Pee Cee Cosma Sope Ltd has declared a 30% dividend, amounting to ₹3 per share, with an ex-date of September 20, 2024. While recent returns show volatility, the company has demonstrated strong long-term growth, particularly in price appreciation.

Pee Cee Cosma Sope Ltd has declared a 30% dividend.<BR><BR>Dividend Details:<BR>- Percentage announced: 30%<BR>- Amount per share: 3<BR>- Ex-date: 20 Sep 24<BR><BR>Dividend Yield: 1.03%.<BR><BR>Total Returns by Period:<BR>In the last 6 months, the price return was -26.73%, with a dividend return of 0%, resulting in a total return of -26.73%.<BR><BR>Over the past year, the price return was 18.52%, the dividend return was 0.69%, leading to a total return of 19.21%.<BR><BR>In the 2-year period, the price return was 134.15%, the dividend return was 2.48%, culminating in a total return of 136.63%.<BR><BR>For the 3-year period, the price return was 342.05%, with a dividend return of 5.66%, resulting in a total return of 347.71%.<BR><BR>In the last 4 years, the price return was 213.67%, the dividend return was 5.68%, leading to a total return of 219.35%.<BR><BR>Over the past 5 years, the price return was 503.07%, with a dividend return of 11.79%, resulting in a total return of 514.86%.<BR><BR>Overall, Pee Cee Cosma has declared a significant dividend, and while the recent returns over shorter periods show volatility, the longer-term returns indicate strong growth, particularly in price appreciation.

Read More

Who are the peers of the Pee Cee Cosma?

03-Jun-2025

Pee Cee Cosma's peers include Hind. Unilever, ITC, Nestle India, Britannia Inds., Godrej Consumer, Terai Tea Co, Palash Securi., Kothari Ferment., and Tanvi Foods. Management risk varies from excellent at ITC and Nestle India to below average at Terai Tea Co and others, with Pee Cee Cosma showing average growth and a 1-year return of 13.31%.

Peers: The peers of Pee Cee Cosma are Hind. Unilever, ITC, Nestle India, Britannia Inds., Godrej Consumer, Terai Tea Co, Palash Securi., Kothari Ferment., Tanvi Foods.<BR><BR>Quality Snapshot: Excellent management risk is observed at ITC, Nestle India, and Britannia Inds., while Good management risk is found at Hind. Unilever and Godrej Consumer. Average management risk is present at Pee Cee Cosma, and Below Average management risk is noted at Terai Tea Co, Palash Securi., Kothari Ferment., and Tanvi Foods. Growth is Average at Pee Cee Cosma, Average at Nestle India, and Below Average at Hind. Unilever, ITC, Godrej Consumer, Britannia Inds., Terai Tea Co, Palash Securi., Kothari Ferment., and Tanvi Foods. Capital Structure is Excellent at Hind. Unilever, ITC, Nestle India, Britannia Inds., Godrej Consumer, and Palash Securi., Good at Pee Cee Cosma, and Below Average at Terai Tea Co, Kothari Ferment., Tanvi Foods.<BR><BR>Return Snapshot: The peer with the highest 1-year return is Terai Tea Co at 108.38%, while the peer with the lowest is Tanvi Foods at -53.58%. Pee Cee Cosma's 1-year return is 13.31%, which is significantly higher than Tanvi Foods but lower than Terai Tea Co. Additionally, Palash Securi., Kothari Ferment., and Tanvi Foods have negative six-month returns.

Read More

What is the technical trend for Pee Cee Cosma?

09-Jun-2025

As of May 23, 2025, Pee Cee Cosma's trend has shifted to bearish with moderate strength, driven by bearish indicators like the MACD and moving averages, despite some bullish momentum in the RSI.

As of 23 May 2025, the technical trend for Pee Cee Cosma has changed from mildly bearish to bearish. The current stance is bearish with moderate strength. Key indicators driving this include a bearish MACD on the weekly chart, bearish moving averages on the daily chart, and a bearish KST on the weekly chart. The Bollinger Bands also indicate a mildly bearish trend on both weekly and monthly time frames. The RSI shows bullish momentum on the weekly, but this is overshadowed by the overall bearish signals. The Dow Theory indicates no trend on both weekly and monthly time frames, suggesting a lack of directional conviction.

Read More

What does Pee Cee Cosma do?

17-Jul-2025

Pee Cee Cosma Sope Ltd manufactures laundry soap and detergent powder, operating as a micro-cap company in the FMCG sector. As of March 2025, it reported net sales of 362 Cr and a net profit of 6 Cr, with a market cap of INR 121 Cr.

Overview:<BR>Pee Cee Cosma Sope Ltd is engaged in the manufacturing of laundry soap, detergent powder, and cake, operating within the FMCG industry and classified as a micro-cap company.<BR><BR>History:<BR>The company was incorporated in November 1986 by a private Indian party and became a public limited company in 1989. The latest quarterly results reported net sales and profit for March 2025.<BR><BR>Financial Snapshot:<BR>- Net Sales: 362 Cr (Quarterly Results - Mar 2025)<BR>- Net Profit: 6 Cr (Quarterly Results - Mar 2025)<BR>- Market-cap: INR 121 Cr (Micro Cap)<BR><BR>Key Metrics:<BR>- P/E: 12.00<BR>- Industry P/E: 56<BR>- Dividend Yield: 1.11%<BR>- Debt Equity: -0.14<BR>- Return on Equity: 20.73%<BR>- Price to Book: 2.59<BR><BR>Contact Details:<BR>Address: Padam Deep 5th Floor, G-10/8 Sanjay Place Agra Uttar Pradesh : 282002<BR>Tel: 91-0562-2527332<BR>Email: pccosmalisting@doctorsoap.com<BR>Website: http://www.peeceecosma.com

Read More

Who are the top shareholders of the Pee Cee Cosma?

17-Jul-2025

The top shareholder of Pee Cee Cosma is Ankit Jain, holding 9.44%, with individual investors collectively owning 20.67%. There are no pledged promoter holdings, mutual funds, or foreign institutional investors involved.

The top shareholders of Pee Cee Cosma primarily consist of promoters, with Ankit Jain being the individual with the highest holding at 9.44%. There are no pledged promoter holdings, and the company does not have any mutual funds or foreign institutional investors (FIIs) holding shares. Additionally, individual investors collectively hold 20.67% of the shares. There are no significant public shareholders listed.

Read More

When is the next results date for Pee Cee Cosma?

01-Aug-2025

The next results date for Pee Cee Cosma is August 7, 2025.

The next results date for Pee Cee Cosma is scheduled for August 7, 2025.

Read More

Are Pee Cee Cosma latest results good or bad?

12-Nov-2025

Pee Cee Cosma's latest results are concerning, showing a 5.49% revenue growth but a sharp 45.49% decline in net profit and a significant drop in operating margins, indicating serious operational challenges and a negative outlook for the company.

Pee Cee Cosma's latest results indicate a challenging performance for the company. While there was a modest revenue growth of 5.49% year-on-year, this was overshadowed by significant declines in profitability. The net profit for the quarter fell sharply by 45.49% compared to the same period last year, and operating margins contracted dramatically from 10.18% to just 5.73%. <BR><BR>Moreover, the sequential performance was equally concerning, with net profit declining 50.17% from the previous quarter. This suggests deteriorating operational efficiency, particularly in their core soap and detergent manufacturing business. The company's stock has also underperformed significantly, declining 48.35% over the past year, which raises concerns about its competitive positioning in a tough market.<BR><BR>Overall, the results reflect serious operational challenges, particularly in maintaining margins and profitability, leading to a negative outlook for the company.

Read More

How has been the historical performance of Pee Cee Cosma?

12-Nov-2025

Pee Cee Cosma's historical performance shows increased net sales and total assets, but declines in operating profit, profit before tax, and cash flow from operations over the past year. Overall, while sales growth is evident, profitability has decreased.

Answer:<BR>The historical performance of Pee Cee Cosma shows a mixed trend in its financial metrics over the past year.<BR><BR>Breakdown:<BR>In the fiscal year ending March 2025, Pee Cee Cosma reported net sales of 144.34 Cr, an increase from 133.64 Cr in March 2024. The total operating income also rose to 144.34 Cr from 133.64 Cr, while total expenditure increased to 131.30 Cr from 118.29 Cr. The operating profit (PBDIT) excluding other income decreased to 13.04 Cr from 15.35 Cr, leading to an overall operating profit of 14.81 Cr, down from 15.95 Cr. Profit before tax fell to 12.94 Cr from 14.05 Cr, and profit after tax decreased to 9.64 Cr from 10.44 Cr. The earnings per share (EPS) also declined to 36.38 from 39.4. On the balance sheet, total assets increased to 57.39 Cr from 47.84 Cr, with total liabilities rising to 57.39 Cr from 47.84 Cr. The book value per share adjusted rose to 183.54 from 152.23. Cash flow from operating activities decreased to 7.00 Cr from 10.00 Cr, while cash flow from investing activities remained stable at -5.00 Cr. Overall, the financial performance indicates growth in sales and assets but a decline in profitability and cash flow from operations.

Read More

How has been the historical performance of Pee Cee Cosma?

13-Nov-2025

Pee Cee Cosma's historical performance shows mixed results, with net sales increasing to 144.34 crore but a decline in operating profit and profit after tax, reflecting challenges in profitability despite growth in sales and total assets. Cash flow from operations also decreased, indicating further financial difficulties.

Answer:<BR>The historical performance of Pee Cee Cosma shows a mixed trend in financial metrics over the past year.<BR><BR>Breakdown:<BR>In the fiscal year ending March 2025, Pee Cee Cosma reported net sales of 144.34 crore, an increase from 133.64 crore in March 2024. However, total operating income remained the same as net sales, with no other operating income reported. The raw material cost rose significantly to 104.84 crore from 90.30 crore, contributing to a total expenditure of 131.30 crore, up from 118.29 crore the previous year. Consequently, the operating profit (PBDIT) decreased to 14.81 crore from 15.95 crore, reflecting a decline in the operating profit margin from 11.49% to 9.03%. Profit before tax also fell to 12.94 crore from 14.05 crore, leading to a profit after tax of 9.64 crore, down from 10.44 crore, resulting in a PAT margin decrease from 7.81% to 6.68%. On the balance sheet, total assets increased to 57.39 crore from 47.84 crore, while total liabilities also rose to 57.39 crore, up from 47.84 crore. The book value per share improved to 183.54 from 152.23. Cash flow from operating activities decreased to 7.00 crore from 10.00 crore, and the net cash inflow/outflow remained at 0.00 crore for the last two years. Overall, while sales and total assets showed growth, profitability metrics and cash flow from operations indicated challenges for the company.

Read More

Should I buy, sell or hold Pee Cee Cosma?

14-Nov-2025

Why is Pee Cee Cosma falling/rising?

04-Dec-2025

As of 04-Dec, the stock price of Pee Cee Cosma Sope Ltd is currently at Rs. 388.50, reflecting a short-term rise after a trend reversal, but it has declined significantly over the past week, month, and year, indicating a cautious investor sentiment.

As of 04-Dec, the stock price of Pee Cee Cosma Sope Ltd is rising, currently at Rs. 388.50, reflecting an increase of Rs. 3.2 or 0.83%. This rise comes after a trend reversal, as the stock has gained following four consecutive days of decline. Notably, the stock opened with a significant gap up of 4.85% today and reached an intraday high of Rs. 404. <BR><BR>Despite this upward movement, it is important to consider the broader context of the stock's performance. Over the past week, the stock has decreased by 5.93%, and it has experienced a substantial decline of 20.36% over the past month. Year-to-date, the stock is down 34.46%, and over the past year, it has fallen by 41.53%. Additionally, the stock is currently trading below its 5-day, 20-day, 50-day, 100-day, and 200-day moving averages, indicating a longer-term downward trend.<BR><BR>Investor participation appears to be declining, with a notable drop in delivery volume by 19.98% compared to the 5-day average. Furthermore, the stock hit a new 52-week low of Rs. 385 earlier today. While the stock has shown a short-term rise, these factors suggest that the overall sentiment towards Pee Cee Cosma remains cautious, with significant challenges in its recent performance.

Read More

Is Pee Cee Cosma overvalued or undervalued?

05-Dec-2025

As of December 4, 2025, Pee Cee Cosma is fairly valued with a PE ratio of 12.79 and an EV to EBITDA of 8.03, especially when compared to overvalued peers like Hindustan Unilever and Nestle India, despite its year-to-date stock performance lagging at -34.46% against the Sensex's 9.12%.

As of 4 December 2025, the valuation grade for Pee Cee Cosma has moved from attractive to fair, indicating a shift in market perception. The company is currently fairly valued based on its financial metrics. Key ratios include a PE ratio of 12.79, an EV to EBITDA of 8.03, and a ROE of 15.16%. <BR><BR>In comparison to its peers, Pee Cee Cosma's valuation stands out against Hindustan Unilever, which has a PE ratio of 54.69, and Nestle India, with a PE of 80. This suggests that while Pee Cee Cosma is fairly valued, its peers are significantly overvalued. Additionally, the company's recent stock performance has lagged behind the Sensex, with a year-to-date return of -34.46% compared to the Sensex's 9.12%, reinforcing the notion of a fair valuation amidst a challenging market environment.

Read More
iScoreScore
Click here to find our call on this stock
Strong Sell
Sell
Hold
Buy
Strong Buy

MarketsMojo — Loved in India, Now Global

The power of Mojo is now in 29 countries. Explore global equities with the same cutting-edge features you love.

Dashboard
1

Poor long term growth as Net Sales has grown by an annual rate of 12.75% and Operating profit at 13.97% over the last 5 years

 
2

The company has declared Negative results for the last 3 consecutive quarters

3

Underperformed the market in the last 1 year

stock-summaryMojo Parameters
Mojo Parameters
Loading Valuation Snapshot...
Stock DNA
stock-summary
Industry

FMCG

stock-summary
Market cap

INR 108 Cr (Micro Cap)

stock-summary
P/E

13.00

stock-summary
Industry P/E

54

stock-summary
Dividend Yield

0.77%

stock-summary
Debt Equity

-0.25

stock-summary
Return on Equity

15.16%

stock-summary
Price to Book

1.94

Revenue and Profits:
Net Sales:
33 Cr
(Quarterly Results - Sep 2025)
Net Profit:
1 Cr
stock-summaryTotal Returns
Total Returns (Price + Dividend) stock-summary
Dividend Yield (0.77%)
TimePeriod
Price Return
Dividend Return
Total Return
3 Months
-15.07%
0.64%
-14.43%
6 Months
-18.51%
0.62%
-17.89%
1 Year
-41.11%
0.48%
-40.63%
2 Years
-10.47%
1.49%
-8.98%
3 Years
222.16%
6.96%
229.12%
4 Years
198.48%
7.15%
205.63%
5 Years
304.73%
11.64%
316.37%

Latest dividend: 3 per share ex-dividend date: Sep-19-2025

Risk Adjusted Returns v/s stock-summary
Returns Beta
Icon
Beta has not been calculated since enough price history is not available
stock-summaryNews & Corporate Actions
News
Announcements stock-summary

Announcement under Regulation 30 (LODR)-Newspaper Publication

14-Nov-2025 | Source : BSE

newspaper publication of extract of unaudited financial results(consolidated and standalone) for the quarter and half year ended 30.09.2025.

Board Meeting Outcome for Outcome Of Board Meeting

11-Nov-2025 | Source : BSE

Board meeting outcome to consider and approve unaudited financial results(standalone and consolidated) for the quarter ended 30.09.2025

FINANCIAL RESULTS FOR THE QUARTER ENDED 30.09.2025

11-Nov-2025 | Source : BSE

UNAUDITED FINANCIAL RESULTS FOR THE QUARTER AND HALF YEAR ENDED 30.09.2025

Corporate Actions stock-summary
stock-summary
BOARD MEETING

No Upcoming Board Meetings

stock-summary
DIVIDEND

Pee Cee Cosma Sope Ltd has declared 30% dividend, ex-date: 19 Sep 25

stock-summary
SPLITS

No Splits history available

stock-summary
BONUS

No Bonus history available

stock-summary
RIGHTS

No Rights history available

stock-summaryKey Factors
Quality key factors stock-summary
Factor
Value
Sales Growth (5y)
12.75%
EBIT Growth (5y)
13.97%
EBIT to Interest (avg)
7.58
Debt to EBITDA (avg)
1.11
Net Debt to Equity (avg)
-0.25
Sales to Capital Employed (avg)
2.75
Tax Ratio
25.87%
Dividend Payout Ratio
21.29%
Pledged Shares
0
Institutional Holding
0.78%
ROCE (avg)
21.35%
ROE (avg)
14.83%
Valuation key factors
Factor
Value
P/E Ratio
13
Industry P/E
54
Price to Book Value
1.94
EV to EBIT
9.48
EV to EBITDA
8.03
EV to Capital Employed
2.25
EV to Sales
0.63
PEG Ratio
NA
Dividend Yield
0.77%
ROCE (Latest)
23.72%
ROE (Latest)
15.16%
Technicals key factors
Indicator
Weekly
Monthly
MACD
Bearish
Mildly Bearish
RSI
No Signal
Bullish
Bollinger Bands
Bearish
Bearish
Moving Averages
Bearish (Daily)
KST
Bearish
Mildly Bearish
Dow Theory
Mildly Bearish
Mildly Bearish
stock-summary Technical Indicator Scale: Bearish, Mildly Bearish, Sideways, Mildly Bullish, Bullish  Turned 
stock-summaryShareholding
Shareholding Snapshot : Sep 2025stock-summary
Shareholding Compare (%holding) stock-summary
Majority shareholders

Promoters

Pledged Promoter Holdings

None

Mutual Funds

Held by 0 Schemes

FIIs

Held by 0 FIIs

Promoter with highest holding

Ankit Jain (9.44%)

Highest Public shareholder

None

Individual Investors Holdings

21.16%

stock-summaryFinancial
[
  {
    "link": "quarterly",
    "btn_text": "All Quarterly Results",
    "header": "Quarterly Results Snapshot (Standalone) - Sep'25 - YoY",
    "rhs": [
      {
        "prefix": "Net Sales ",
        "suffix": "YoY Growth in quarter ended Sep 2025 is 5.49% vs -5.00% in Sep 2024",
        "dir": 1
      },
      {
        "prefix": "Standalone Net Profit ",
        "suffix": "YoY Growth in quarter ended Sep 2025 is -45.11% vs 5.98% in Sep 2024",
        "dir": -1
      }
    ],
    "table": {
      "header": [
        "Sep'25",
        "Sep'24",
        "Change(%)"
      ],
      "body": [
        {
          "field": "Net Sales",
          "val1": "32.64",
          "val2": "30.94",
          "chgp": "5.49%",
          "chgp_class": "positive"
        },
        {
          "field": "Operating Profit (PBDIT) excl Other Income",
          "val1": "1.89",
          "val2": "3.15",
          "chgp": "-40.00%",
          "chgp_class": "negative"
        },
        {
          "field": "Interest",
          "val1": "0.01",
          "val2": "0.05",
          "chgp": "-80.00%",
          "chgp_class": "positive"
        },
        {
          "field": "Exceptional Items",
          "val1": "0.00",
          "val2": "0.00",
          "chgp": "",
          "chgp_class": "neutral"
        },
        {
          "field": "Standalone Net Profit",
          "val1": "1.46",
          "val2": "2.66",
          "chgp": "-45.11%",
          "chgp_class": "negative"
        },
        {
          "field": "Operating Profit Margin (Excl OI)",
          "val1": "5.79%",
          "val2": "10.18%",
          "chgp": "-4.39%",
          "chgp_class": "negative"
        }
      ]
    }
  },
  {
    "link": "half-yearly",
    "btn_text": "All Half Yearly Results",
    "header": "Half Yearly Results Snapshot (Standalone) - Sep'25",
    "rhs": [
      {
        "prefix": "Net Sales ",
        "suffix": " Growth in half year ended Sep 2025 is 2.34% vs 2.14% in Sep 2024",
        "dir": 1
      },
      {
        "prefix": "Standalone Net Profit ",
        "suffix": " Growth in half year ended Sep 2025 is -25.96% vs 21.66% in Sep 2024",
        "dir": -1
      }
    ],
    "table": {
      "header": [
        "Sep'25",
        "Sep'24",
        "Change(%)"
      ],
      "body": [
        {
          "field": "Net Sales",
          "val1": "72.45",
          "val2": "70.79",
          "chgp": "2.34%",
          "chgp_class": "positive"
        },
        {
          "field": "Operating Profit (PBDIT) excl Other Income",
          "val1": "5.46",
          "val2": "7.31",
          "chgp": "-25.31%",
          "chgp_class": "negative"
        },
        {
          "field": "Interest",
          "val1": "0.03",
          "val2": "0.07",
          "chgp": "-57.14%",
          "chgp_class": "positive"
        },
        {
          "field": "Exceptional Items",
          "val1": "0.00",
          "val2": "0.00",
          "chgp": "",
          "chgp_class": "neutral"
        },
        {
          "field": "Standalone Net Profit",
          "val1": "4.45",
          "val2": "6.01",
          "chgp": "-25.96%",
          "chgp_class": "negative"
        },
        {
          "field": "Operating Profit Margin (Excl OI)",
          "val1": "7.54%",
          "val2": "10.33%",
          "chgp": "-2.79%",
          "chgp_class": "negative"
        }
      ]
    }
  },
  {
    "link": "nine-monthly",
    "btn_text": "All Nine Monthly Results",
    "header": "Nine Monthly Results Snapshot (Standalone) - Dec'24",
    "rhs": [
      {
        "prefix": "Net Sales ",
        "suffix": "YoY Growth in nine months ended Dec 2024 is 1.93% vs 8.65% in Dec 2023",
        "dir": -1
      },
      {
        "prefix": "Standalone Net Profit ",
        "suffix": "YoY Growth in nine months ended Dec 2024 is 15.78% vs 650.49% in Dec 2023",
        "dir": -1
      }
    ],
    "table": {
      "header": [
        "Dec'24",
        "Dec'23",
        "Change(%)"
      ],
      "body": [
        {
          "field": "Net Sales",
          "val1": "105.10",
          "val2": "103.11",
          "chgp": "1.93%",
          "chgp_class": "positive"
        },
        {
          "field": "Operating Profit (PBDIT) excl Other Income",
          "val1": "11.53",
          "val2": "11.46",
          "chgp": "0.61%",
          "chgp_class": "positive"
        },
        {
          "field": "Interest",
          "val1": "0.16",
          "val2": "0.27",
          "chgp": "-40.74%",
          "chgp_class": "positive"
        },
        {
          "field": "Exceptional Items",
          "val1": "0.00",
          "val2": "0.00",
          "chgp": "",
          "chgp_class": "neutral"
        },
        {
          "field": "Standalone Net Profit",
          "val1": "8.95",
          "val2": "7.73",
          "chgp": "15.78%",
          "chgp_class": "positive"
        },
        {
          "field": "Operating Profit Margin (Excl OI)",
          "val1": "10.97%",
          "val2": "11.11%",
          "chgp": "-0.14%",
          "chgp_class": "negative"
        }
      ]
    }
  },
  {
    "link": "annual",
    "btn_text": "All Annual Results",
    "header": "Annual Results Snapshot (Standalone) - Mar'25",
    "rhs": [
      {
        "prefix": "Net Sales ",
        "suffix": "YoY Growth in year ended Mar 2025 is 5.20% vs 7.32% in Mar 2024",
        "dir": -1
      },
      {
        "prefix": "Standalone Net Profit ",
        "suffix": "YoY Growth in year ended Mar 2025 is -7.95% vs 319.28% in Mar 2024",
        "dir": -1
      }
    ],
    "table": {
      "header": [
        "Mar'25",
        "Mar'24",
        "Change(%)"
      ],
      "body": [
        {
          "field": "Net Sales",
          "val1": "140.59",
          "val2": "133.64",
          "chgp": "5.20%",
          "chgp_class": "positive"
        },
        {
          "field": "Operating Profit (PBDIT) excl Other Income",
          "val1": "13.01",
          "val2": "15.35",
          "chgp": "-15.24%",
          "chgp_class": "negative"
        },
        {
          "field": "Interest",
          "val1": "0.22",
          "val2": "0.30",
          "chgp": "-26.67%",
          "chgp_class": "positive"
        },
        {
          "field": "Exceptional Items",
          "val1": "0.00",
          "val2": "0.00",
          "chgp": "",
          "chgp_class": "neutral"
        },
        {
          "field": "Standalone Net Profit",
          "val1": "9.61",
          "val2": "10.44",
          "chgp": "-7.95%",
          "chgp_class": "negative"
        },
        {
          "field": "Operating Profit Margin (Excl OI)",
          "val1": "9.25%",
          "val2": "11.49%",
          "chgp": "-2.24%",
          "chgp_class": "negative"
        }
      ]
    }
  }
]
Quarterly Results Snapshot (Standalone) - Sep'25 - YoYstock-summary
Sep'25
Sep'24
Change(%)
Net Sales
32.64
30.94
5.49%
Operating Profit (PBDIT) excl Other Income
1.89
3.15
-40.00%
Interest
0.01
0.05
-80.00%
Exceptional Items
0.00
0.00
Standalone Net Profit
1.46
2.66
-45.11%
Operating Profit Margin (Excl OI)
5.79%
10.18%
-4.39%
Values in Rs Cr.
Direction Arrows
Net Sales

YoY Growth in quarter ended Sep 2025 is 5.49% vs -5.00% in Sep 2024

Direction Arrows
Standalone Net Profit

YoY Growth in quarter ended Sep 2025 is -45.11% vs 5.98% in Sep 2024

Half Yearly Results Snapshot (Standalone) - Sep'25stock-summary
Sep'25
Sep'24
Change(%)
Net Sales
72.45
70.79
2.34%
Operating Profit (PBDIT) excl Other Income
5.46
7.31
-25.31%
Interest
0.03
0.07
-57.14%
Exceptional Items
0.00
0.00
Standalone Net Profit
4.45
6.01
-25.96%
Operating Profit Margin (Excl OI)
7.54%
10.33%
-2.79%
Values in Rs Cr.
Direction Arrows
Net Sales

Growth in half year ended Sep 2025 is 2.34% vs 2.14% in Sep 2024

Direction Arrows
Standalone Net Profit

Growth in half year ended Sep 2025 is -25.96% vs 21.66% in Sep 2024

Nine Monthly Results Snapshot (Standalone) - Dec'24stock-summary
Dec'24
Dec'23
Change(%)
Net Sales
105.10
103.11
1.93%
Operating Profit (PBDIT) excl Other Income
11.53
11.46
0.61%
Interest
0.16
0.27
-40.74%
Exceptional Items
0.00
0.00
Standalone Net Profit
8.95
7.73
15.78%
Operating Profit Margin (Excl OI)
10.97%
11.11%
-0.14%
Values in Rs Cr.
Direction Arrows
Net Sales

YoY Growth in nine months ended Dec 2024 is 1.93% vs 8.65% in Dec 2023

Direction Arrows
Standalone Net Profit

YoY Growth in nine months ended Dec 2024 is 15.78% vs 650.49% in Dec 2023

Annual Results Snapshot (Standalone) - Mar'25stock-summary
Mar'25
Mar'24
Change(%)
Net Sales
140.59
133.64
5.20%
Operating Profit (PBDIT) excl Other Income
13.01
15.35
-15.24%
Interest
0.22
0.30
-26.67%
Exceptional Items
0.00
0.00
Standalone Net Profit
9.61
10.44
-7.95%
Operating Profit Margin (Excl OI)
9.25%
11.49%
-2.24%
Values in Rs Cr.
Direction Arrows
Net Sales

YoY Growth in year ended Mar 2025 is 5.20% vs 7.32% in Mar 2024

Direction Arrows
Standalone Net Profit

YoY Growth in year ended Mar 2025 is -7.95% vs 319.28% in Mar 2024

stock-summaryCompany CV
About Pee Cee Cosma Sope Ltd stock-summary
stock-summary
Pee Cee Cosma Sope Ltd
Micro Cap
FMCG
Pee Cee Cosma Sope Limited was incorporated in November, 1986 by a private Indian party. The Company is engaged in the business of Manufacturing of Laundry Soap, Detergent Powder and Cake operating in State of Uttar Pradesh, Rajasthan and Madhya Pradesh. Company became a public limited company in 1989 and its shares got listed on the Bombay Stock Exchange Ltd.
Company Coordinates stock-summary
Company Details
Padam Deep 5th Floor, G-10/8 Sanjay Place Agra Uttar Pradesh : 282002
stock-summary
Tel: 91-0562-2527332
stock-summary
pccosmalisting@doctorsoap.com
Registrar Details
Skyline Financial Services Pvt Ltd , D-153/A, 1st Floor, Okhla Industrial Area, Phase - I, New Delhi